BETHEL, Conn., Nov. 5, 2020 /PRNewswire/ — Sonata Scientific LLC, a developer of advanced air purification and antimicrobial products, has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $256,000 to conduct research and development (R&D) work on reducing the transmission of COVID-19 by contaminated surfaces.
The company is developing products to treat hospital surfaces that are known to harbor SARS-CoV-2 and other pathogens.
Sonata is creating novel surfaces that kill both the COVID-19 virus and bacteria that cause hospital acquired infections. Even with daily wipe downs, these microscopic species accumulate on hospital surfaces such as bed rails and tables. Sonata Scientific’s light activated, non-toxic durable coating works continuously to reduce dangerous infections and save lives.
“NSF is proud to support the technology of the future by thinking beyond incremental developments and funding the most creative, impactful ideas across all markets and areas of